Aytu BioPharma Inc — Cash Flow (NASDAQ:AYTU) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 26 M28.8 M5.1 M1.39 M1.94 M 3.28 M Cash from investing activities 2.78 M3.25 M117 K329 K2.56 M 2.05 M Cash from financing activities 30.31 M1.53 M8.87 M1.26 M15.44 M 17.56 M Free cash flow 26 M28.8 M5.1 M1.39 M-1.29 M 3.26 M

Новости

Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript

Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates

Доходы Aytu BioPharma падают, акции снижаются после отчета

Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls

New Strong Sell Stocks for February 2nd

Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript

Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20

Aytu запускает EXXUA - первый селективный агонист 5-HT1A от депрессии

Aytu launches EXXUA, first selective 5-HT1A agonist for depression

Акции Aytu BioPharma растут после запуска препарата от депрессии EXXUA

Aytu BioPharma stock rises after commercial launch of depression drug EXXUA

Aytu BioPharma launches depression drug EXXUA in U.S. market